613 related articles for article (PubMed ID: 18310816)
1. [Assessment of bone quality. Bone quality and osteoporosis treatment].
Mashiba T
Clin Calcium; 2008 Mar; 18(3):300-7. PubMed ID: 18310816
[TBL] [Abstract][Full Text] [Related]
2. [Contribution of bone quality to fracture risk].
Mori S
Clin Calcium; 2004 Oct; 14(10):33-8. PubMed ID: 15577129
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of action of antiresorptive therapies of postmenopausal osteoporosis.
Stepan JJ; Alenfeld F; Boivin G; Feyen JH; Lakatos P
Endocr Regul; 2003 Dec; 37(4):225-38. PubMed ID: 15106819
[TBL] [Abstract][Full Text] [Related]
4. Influence of the selective oestrogen receptor modulator (raloxifene hydrochloride) on IL-6, TNF-alpha, TGF-beta1 and bone turnover markers in the treatment of postmenopausal osteoporosis.
Ozmen B; Kirmaz C; Aydin K; Kafesciler SO; Guclu F; Hekimsoy Z
Eur Cytokine Netw; 2007 Sep; 18(3):148-53. PubMed ID: 17823083
[TBL] [Abstract][Full Text] [Related]
5. [Bone remodeling].
Lerner UH; Ljunggren O
Lakartidningen; 2006 Oct 4-10; 103(40):2972-5. PubMed ID: 17115661
[No Abstract] [Full Text] [Related]
6. [Evidence for the selective estrogen receptor modulator raloxifene: its evolving role in the treatment of osteoporosis].
Ohta H
Clin Calcium; 2008 Oct; 18(10):1442-50. PubMed ID: 18830041
[TBL] [Abstract][Full Text] [Related]
7. Effect of zoledronic acid compared with raloxifene on bone turnover markers in postmenopausal women with low bone density.
Bachmann G; Kriegman A; Gonçalves J; Kianifard F; Warren M; Simon JA
Menopause; 2011 Aug; 18(8):851-6. PubMed ID: 21796066
[TBL] [Abstract][Full Text] [Related]
8. [Effects of SERMs on bone health. Effects of raloxifene and bisphosphonate on bone quality in osteoporosis: collagen cross-links, mineralization, and bone strength].
Saito M
Clin Calcium; 2010 Mar; 20(3):345-54. PubMed ID: 20190364
[TBL] [Abstract][Full Text] [Related]
9. Lasofoxifene: new drug. Osteoporosis: no better than raloxifene.
Prescrire Int; 2009 Dec; 18(104):247. PubMed ID: 20020572
[No Abstract] [Full Text] [Related]
10. [Morphological analysis of bone dynamics and metabolic bone disease. Pathophisiology of Microdamage].
Mori S
Clin Calcium; 2011 Apr; 21(4):559-65. PubMed ID: 21447923
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of osteoporosis with antiresorptive drugs].
Vestergaard P; Mosekilde L; Brixen K
Ugeskr Laeger; 2005 Feb; 167(8):883-7. PubMed ID: 15789840
[No Abstract] [Full Text] [Related]
12. [Evidence of raloxifene on postmenopausal osteoporosis].
Okano H
Nihon Rinsho; 2007 Nov; 65 Suppl 9():374-80. PubMed ID: 18161135
[No Abstract] [Full Text] [Related]
13. Clinical effects of bisphosphonates in involutional osteoporosis.
Ott SM
J Bone Miner Res; 1993 Dec; 8 Suppl 2():S597-606. PubMed ID: 8122531
[TBL] [Abstract][Full Text] [Related]
14. [Biochemical markers of bone turnover. New aspect. Effects of androgen and estrogen on biochemical markers of bone turnover].
Ohnaka K; Takayanagi R
Clin Calcium; 2009 Aug; 19(8):1118-24. PubMed ID: 19638695
[TBL] [Abstract][Full Text] [Related]
15. The bone quality framework: determinants of bone strength and their interrelationships, and implications for osteoporosis management.
Felsenberg D; Boonen S
Clin Ther; 2005 Jan; 27(1):1-11. PubMed ID: 15763602
[TBL] [Abstract][Full Text] [Related]
16. [Accumulation of microdamage in bone].
Mori S
Nihon Rinsho; 2007 Nov; 65 Suppl 9():203-8. PubMed ID: 18161107
[No Abstract] [Full Text] [Related]
17. Is bone mineral density predictive of fracture risk reduction?
Cefalu CA
Curr Med Res Opin; 2004 Mar; 20(3):341-9. PubMed ID: 15025843
[TBL] [Abstract][Full Text] [Related]
18. [Bisphosphonate therapy for osteoporosis and bone strength].
Kishimoto H
Clin Calcium; 2006 Sep; 16(9):1513-19. PubMed ID: 16951477
[TBL] [Abstract][Full Text] [Related]
19. [Current topics in drug therapy aiming at bone resorption].
Yasui T; Tanaka S
Clin Calcium; 2006 Sep; 16(9):1475-79. PubMed ID: 16951471
[TBL] [Abstract][Full Text] [Related]
20. Sustained vertebral antifracture efficacy of oral anti-osteoporotic therapies in postmenopausal osteoporosis.
Brandi ML
Curr Med Res Opin; 2010 Nov; 26(11):2553-63. PubMed ID: 20858031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
